Your browser doesn't support javascript.
Natural killer cells for antiviral therapy.
Smith, Davey M; Schafer, Jolie R; Tullius, Brian; Witkam, Laura; Paust, Silke.
  • Smith DM; Department of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
  • Schafer JR; Kiadis Pharma, Sanofi, 1105BP Amsterdam, Netherlands.
  • Tullius B; Advent Health for Children, Orlando, FL 32804, USA.
  • Witkam L; Kiadis Pharma, Sanofi, 1105BP Amsterdam, Netherlands.
  • Paust S; Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.
Sci Transl Med ; 15(677): eabl5278, 2023 01 04.
Article in English | MEDLINE | ID: covidwho-2319413
ABSTRACT
Natural killer (NK) cell-based immunotherapy is being explored for treating infectious diseases, including viral infections. Here, we discuss evidence of NK cell responses to different viruses, ongoing clinical efforts to treat such infections with NK cell products, and review platforms to generate NK cell products.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Killer Cells, Natural / Immunotherapy Type of study: Prognostic study Language: English Journal: Sci Transl Med Journal subject: Science / Medicine Year: 2023 Document Type: Article Affiliation country: Scitranslmed.abl5278

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Killer Cells, Natural / Immunotherapy Type of study: Prognostic study Language: English Journal: Sci Transl Med Journal subject: Science / Medicine Year: 2023 Document Type: Article Affiliation country: Scitranslmed.abl5278